Why Roche Oncology Bet Big On Neoantigen-Directed T-Cell Therapy

 
• By Emily Hayes
Ship wheel, exploring new frontiers. Digital illustration. - Illustration
Roche wants to chart new directions in T-cell receptor therapies

More from Cell Therapies

More from Advanced Therapies